Rewire Therapeutics Limited
- Company number
- 13966692
- Status
- Active - Proposal To Strike Off
- Type
- Private Limited Company
- Incorporated
- 9 Mar 2022
- Nature of business
- Research and experimental development on biotechnology
Registered office
Officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BLYTH, Alexander William | Director | 9 Mar 2022 |
Control
| Name | Nature of control | Notified | Ceased |
|---|---|---|---|
| Mr Alexander William Blyth | Ownership Of Shares 75 To 100 Percent Voting Rights 75 To 100 Percent Right To Appoint And Remove Directors |
9 Mar 2022 |
Accounts
| Year ended | Net assets | Cash |
|---|---|---|
| 31 Jan 2025 Dormant | £62 | £62 |
| 31 Jan 2024 Dormant | £62 | £62 |
| 31 Jan 2023 Dormant | £61 | £61 |
Connections
Directors’ other companies
- BLYTH, Alexander William - Director at Nutri-Genetix Limited
- BLYTH, Alexander William - Director at Breakthrough Therapy Ventures Ltd
Companies at the same address
- Breakthrough Therapy Ventures Ltd (14239057)
- Viternity Ltd (16701899)